Literature DB >> 21061172

Strictly defined familial male breast cancer.

Uwe Güth1, Dieter Müller, Dorothy Jane Huang, Ellen Obermann, Hansjakob Müller.   

Abstract

The term "familial male breast cancer" is often misleading, because in the breast cancer families reported in the literature, the vast majority of the patients were women and only a few were men. In this report, we present the rare case of a strictly defined familial male breast cancer (MBC) in which exclusively men were diagnosed with breast cancer. Three of four brothers developed the disease between the age of 46 and 64 years within a period of 21 years whereas all female relatives remained unaffected. The three affected men did not show the typical known clinical and genetic risk factors for MBC. An X-linked recessive inheritance may be possible in these cases. One way to potentially improve the identification of the causes of MBC could be a through a strictly studying families in which the male members were exclusively diagnosed with this malignancy. This approach emphasizes familial MBC as a distinct entity and not only as a variant of female breast cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21061172     DOI: 10.1007/s10689-010-9400-3

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  28 in total

1.  Role of CHEK2*1100delC in unselected series of non-BRCA1/2 male breast cancers.

Authors:  Susan Neuhausen; Alison Dunning; Linda Steele; Kazuko Yakumo; Michael Hoffman; Csilla Szabo; Louise Tee; Caroline Baines; Paul Pharoah; David Goldgar; Doug Easton
Journal:  Int J Cancer       Date:  2004-01-20       Impact factor: 7.396

2.  Are PALB2 mutations associated with increased risk of male breast cancer?

Authors:  A Sauty de Chalon; Z Teo; D J Park; F A Odefrey; J L Hopper; M C Southey
Journal:  Breast Cancer Res Treat       Date:  2009-12-20       Impact factor: 4.872

3.  Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.

Authors:  Alfons Meindl; Heide Hellebrand; Constanze Wiek; Verena Erven; Barbara Wappenschmidt; Dieter Niederacher; Marcel Freund; Peter Lichtner; Linda Hartmann; Heiner Schaal; Juliane Ramser; Ellen Honisch; Christian Kubisch; Hans E Wichmann; Karin Kast; Helmut Deissler; Christoph Engel; Bertram Müller-Myhsok; Kornelia Neveling; Marion Kiechle; Christopher G Mathew; Detlev Schindler; Rita K Schmutzler; Helmut Hanenberg
Journal:  Nat Genet       Date:  2010-04-18       Impact factor: 38.330

4.  Familial male breast carcinoma.

Authors:  J G Demeter; N G Waterman; G D Verdi
Journal:  Cancer       Date:  1990-05-15       Impact factor: 6.860

5.  Multidisciplinary meeting on male breast cancer: summary and research recommendations.

Authors:  Larissa A Korde; Jo Anne Zujewski; Leah Kamin; Sharon Giordano; Susan Domchek; William F Anderson; John M S Bartlett; Karen Gelmon; Zeina Nahleh; Jonas Bergh; Bruno Cutuli; Giancarlo Pruneri; Worta McCaskill-Stevens; Julie Gralow; Gabriel Hortobagyi; Fatima Cardoso
Journal:  J Clin Oncol       Date:  2010-03-22       Impact factor: 44.544

6.  Analysis of familial male breast cancer for germline mutations in CHEK2.

Authors:  Nayanta Sodha; Charlotte Wilson; Sarah L Bullock; Hazel Phillimore; Richard S Houlston; Rosalind A Eeles
Journal:  Cancer Lett       Date:  2004-11-25       Impact factor: 8.679

Review 7.  Examining breast cancer growth and lifestyle risk factors: early life, childhood, and adolescence.

Authors:  Elizabeth H Ruder; Joanne F Dorgan; Sibylle Kranz; Penny M Kris-Etherton; Terryl J Hartman
Journal:  Clin Breast Cancer       Date:  2008-08       Impact factor: 3.225

8.  CHEK2 1100delC is not a risk factor for male breast cancer population.

Authors:  Kirsi Syrjäkoski; Tuula Kuukasjärvi; Anssi Auvinen; Olli-P Kallioniemi
Journal:  Int J Cancer       Date:  2004-01-20       Impact factor: 7.396

9.  Significant contribution of germline BRCA2 rearrangements in male breast cancer families.

Authors:  Isabelle Tournier; Brigitte Bressac-de Paillerets; Hagay Sobol; Dominique Stoppa-Lyonnet; Rosette Lidereau; Michel Barrois; Sylvie Mazoyer; Florence Coulet; Agnès Hardouin; Agnès Chompret; Alain Lortholary; Pierre Chappuis; Violaine Bourdon; Valérie Bonadona; Christine Maugard; Brigitte Gilbert; Catherine Nogues; Thierry Frébourg; Mario Tosi
Journal:  Cancer Res       Date:  2004-11-15       Impact factor: 12.701

10.  PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.

Authors:  Nazneen Rahman; Sheila Seal; Deborah Thompson; Patrick Kelly; Anthony Renwick; Anna Elliott; Sarah Reid; Katarina Spanova; Rita Barfoot; Tasnim Chagtai; Hiran Jayatilake; Lesley McGuffog; Sandra Hanks; D Gareth Evans; Diana Eccles; Douglas F Easton; Michael R Stratton
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

View more
  1 in total

Review 1.  Etiology of familial breast cancer with undetected BRCA1 and BRCA2 mutations: clinical implications.

Authors:  Eugenia Yiannakopoulou
Journal:  Cell Oncol (Dordr)       Date:  2013-12-04       Impact factor: 6.730

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.